Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. It is available by mouth, intravenously, and in eye drop form.
Factors such as increasing incidences of bacterial infections such as pneumonia & urinary tract infections (UTI) and broad spectrum efficacy drive the market growth.
However, side effects associated with levofloxacin such as tendon inflammation, psychosis, and seizures restrain the market growth.
Furthermore, rising geriatric population and growing initiatives by the government to spread awareness about severe infections are expected to further drive the market growth.
In 2019, the market size of Levofloxacin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Levofloxacin.
This report studies the global market size of Levofloxacin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Levofloxacin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Alna Biotech Private
Allenge India Pharma
Bestochem
Divine Savior Healthcare
Glenmark Pharmaceuticals
Pax Healthcare
Aden Healthcare
Lupin Pharmaceuticals
Dr. Reddys Laboratories
Zydus Cadila
Market Segment by Product Type
250 mg
500 mg
750 mg
Market Segment by Application
Pneumonia
Skin Infection
Kidney Infection
Bladder Infection
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Levofloxacin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Levofloxacin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Levofloxacin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Factors such as increasing incidences of bacterial infections such as pneumonia & urinary tract infections (UTI) and broad spectrum efficacy drive the market growth.
However, side effects associated with levofloxacin such as tendon inflammation, psychosis, and seizures restrain the market growth.
Furthermore, rising geriatric population and growing initiatives by the government to spread awareness about severe infections are expected to further drive the market growth.
In 2019, the market size of Levofloxacin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Levofloxacin.
This report studies the global market size of Levofloxacin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Levofloxacin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Alna Biotech Private
Allenge India Pharma
Bestochem
Divine Savior Healthcare
Glenmark Pharmaceuticals
Pax Healthcare
Aden Healthcare
Lupin Pharmaceuticals
Dr. Reddys Laboratories
Zydus Cadila
Market Segment by Product Type
250 mg
500 mg
750 mg
Market Segment by Application
Pneumonia
Skin Infection
Kidney Infection
Bladder Infection
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Levofloxacin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Levofloxacin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Levofloxacin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Levofloxacin Market Size Growth Rate by Type (2019-2025)
1.3.2 250 mg
1.3.3 500 mg
1.3.4 750 mg
1.4 Market Segment by Application
1.4.1 Global Levofloxacin Market Share by Application (2019-2025)
1.4.2 Pneumonia
1.4.3 Skin Infection
1.4.4 Kidney Infection
1.4.5 Bladder Infection
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Levofloxacin Market Size
2.1.1 Global Levofloxacin Revenue 2014-2025
2.1.2 Global Levofloxacin Sales 2014-2025
2.2 Levofloxacin Growth Rate by Regions
2.2.1 Global Levofloxacin Sales by Regions 2014-2019
2.2.2 Global Levofloxacin Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Levofloxacin Sales by Manufacturers
3.1.1 Levofloxacin Sales by Manufacturers 2014-2019
3.1.2 Levofloxacin Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Levofloxacin Revenue by Manufacturers (2014-2019)
3.2.2 Levofloxacin Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Levofloxacin Market Concentration Ratio (CR5 and HHI)
3.3 Levofloxacin Price by Manufacturers
3.4 Key Manufacturers Levofloxacin Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Levofloxacin Market
3.6 Key Manufacturers Levofloxacin Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 250 mg Sales and Revenue (2014-2019)
4.1.2 500 mg Sales and Revenue (2014-2019)
4.1.3 750 mg Sales and Revenue (2014-2019)
4.2 Global Levofloxacin Sales Market Share by Type
4.3 Global Levofloxacin Revenue Market Share by Type
4.4 Levofloxacin Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Levofloxacin Sales by Application
6 United States
6.1 United States Levofloxacin Breakdown Data by Company
6.2 United States Levofloxacin Breakdown Data by Type
6.3 United States Levofloxacin Breakdown Data by Application
7 European Union
7.1 European Union Levofloxacin Breakdown Data by Company
7.2 European Union Levofloxacin Breakdown Data by Type
7.3 European Union Levofloxacin Breakdown Data by Application
8 China
8.1 China Levofloxacin Breakdown Data by Company
8.2 China Levofloxacin Breakdown Data by Type
8.3 China Levofloxacin Breakdown Data by Application
9 Rest of World
9.1 Rest of World Levofloxacin Breakdown Data by Company
9.2 Rest of World Levofloxacin Breakdown Data by Type
9.3 Rest of World Levofloxacin Breakdown Data by Application
9.4 Rest of World Levofloxacin Breakdown Data by Countries
9.4.1 Rest of World Levofloxacin Sales by Countries
9.4.2 Rest of World Levofloxacin Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Alna Biotech Private
10.1.1 Alna Biotech Private Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Levofloxacin
10.1.4 Levofloxacin Product Introduction
10.1.5 Alna Biotech Private Recent Development
10.2 Allenge India Pharma
10.2.1 Allenge India Pharma Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Levofloxacin
10.2.4 Levofloxacin Product Introduction
10.2.5 Allenge India Pharma Recent Development
10.3 Bestochem
10.3.1 Bestochem Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Levofloxacin
10.3.4 Levofloxacin Product Introduction
10.3.5 Bestochem Recent Development
10.4 Divine Savior Healthcare
10.4.1 Divine Savior Healthcare Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Levofloxacin
10.4.4 Levofloxacin Product Introduction
10.4.5 Divine Savior Healthcare Recent Development
10.5 Glenmark Pharmaceuticals
10.5.1 Glenmark Pharmaceuticals Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Levofloxacin
10.5.4 Levofloxacin Product Introduction
10.5.5 Glenmark Pharmaceuticals Recent Development
10.6 Pax Healthcare
10.6.1 Pax Healthcare Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Levofloxacin
10.6.4 Levofloxacin Product Introduction
10.6.5 Pax Healthcare Recent Development
10.7 Aden Healthcare
10.7.1 Aden Healthcare Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Levofloxacin
10.7.4 Levofloxacin Product Introduction
10.7.5 Aden Healthcare Recent Development
10.8 Lupin Pharmaceuticals
10.8.1 Lupin Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Levofloxacin
10.8.4 Levofloxacin Product Introduction
10.8.5 Lupin Pharmaceuticals Recent Development
10.9 Dr. Reddys Laboratories
10.9.1 Dr. Reddys Laboratories Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Levofloxacin
10.9.4 Levofloxacin Product Introduction
10.9.5 Dr. Reddys Laboratories Recent Development
10.10 Zydus Cadila
10.10.1 Zydus Cadila Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Levofloxacin
10.10.4 Levofloxacin Product Introduction
10.10.5 Zydus Cadila Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Levofloxacin Sales Channels
11.2.2 Levofloxacin Distributors
11.3 Levofloxacin Customers
12 Market Forecast
12.1 Global Levofloxacin Sales and Revenue Forecast 2019-2025
12.2 Global Levofloxacin Sales Forecast by Type
12.3 Global Levofloxacin Sales Forecast by Application
12.4 Levofloxacin Forecast by Regions
12.4.1 Global Levofloxacin Sales Forecast by Regions 2019-2025
12.4.2 Global Levofloxacin Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Levofloxacin Market Size Growth Rate by Type (2019-2025)
1.3.2 250 mg
1.3.3 500 mg
1.3.4 750 mg
1.4 Market Segment by Application
1.4.1 Global Levofloxacin Market Share by Application (2019-2025)
1.4.2 Pneumonia
1.4.3 Skin Infection
1.4.4 Kidney Infection
1.4.5 Bladder Infection
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Levofloxacin Market Size
2.1.1 Global Levofloxacin Revenue 2014-2025
2.1.2 Global Levofloxacin Sales 2014-2025
2.2 Levofloxacin Growth Rate by Regions
2.2.1 Global Levofloxacin Sales by Regions 2014-2019
2.2.2 Global Levofloxacin Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Levofloxacin Sales by Manufacturers
3.1.1 Levofloxacin Sales by Manufacturers 2014-2019
3.1.2 Levofloxacin Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Levofloxacin Revenue by Manufacturers (2014-2019)
3.2.2 Levofloxacin Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Levofloxacin Market Concentration Ratio (CR5 and HHI)
3.3 Levofloxacin Price by Manufacturers
3.4 Key Manufacturers Levofloxacin Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Levofloxacin Market
3.6 Key Manufacturers Levofloxacin Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 250 mg Sales and Revenue (2014-2019)
4.1.2 500 mg Sales and Revenue (2014-2019)
4.1.3 750 mg Sales and Revenue (2014-2019)
4.2 Global Levofloxacin Sales Market Share by Type
4.3 Global Levofloxacin Revenue Market Share by Type
4.4 Levofloxacin Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Levofloxacin Sales by Application
6 United States
6.1 United States Levofloxacin Breakdown Data by Company
6.2 United States Levofloxacin Breakdown Data by Type
6.3 United States Levofloxacin Breakdown Data by Application
7 European Union
7.1 European Union Levofloxacin Breakdown Data by Company
7.2 European Union Levofloxacin Breakdown Data by Type
7.3 European Union Levofloxacin Breakdown Data by Application
8 China
8.1 China Levofloxacin Breakdown Data by Company
8.2 China Levofloxacin Breakdown Data by Type
8.3 China Levofloxacin Breakdown Data by Application
9 Rest of World
9.1 Rest of World Levofloxacin Breakdown Data by Company
9.2 Rest of World Levofloxacin Breakdown Data by Type
9.3 Rest of World Levofloxacin Breakdown Data by Application
9.4 Rest of World Levofloxacin Breakdown Data by Countries
9.4.1 Rest of World Levofloxacin Sales by Countries
9.4.2 Rest of World Levofloxacin Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Alna Biotech Private
10.1.1 Alna Biotech Private Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Levofloxacin
10.1.4 Levofloxacin Product Introduction
10.1.5 Alna Biotech Private Recent Development
10.2 Allenge India Pharma
10.2.1 Allenge India Pharma Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Levofloxacin
10.2.4 Levofloxacin Product Introduction
10.2.5 Allenge India Pharma Recent Development
10.3 Bestochem
10.3.1 Bestochem Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Levofloxacin
10.3.4 Levofloxacin Product Introduction
10.3.5 Bestochem Recent Development
10.4 Divine Savior Healthcare
10.4.1 Divine Savior Healthcare Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Levofloxacin
10.4.4 Levofloxacin Product Introduction
10.4.5 Divine Savior Healthcare Recent Development
10.5 Glenmark Pharmaceuticals
10.5.1 Glenmark Pharmaceuticals Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Levofloxacin
10.5.4 Levofloxacin Product Introduction
10.5.5 Glenmark Pharmaceuticals Recent Development
10.6 Pax Healthcare
10.6.1 Pax Healthcare Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Levofloxacin
10.6.4 Levofloxacin Product Introduction
10.6.5 Pax Healthcare Recent Development
10.7 Aden Healthcare
10.7.1 Aden Healthcare Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Levofloxacin
10.7.4 Levofloxacin Product Introduction
10.7.5 Aden Healthcare Recent Development
10.8 Lupin Pharmaceuticals
10.8.1 Lupin Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Levofloxacin
10.8.4 Levofloxacin Product Introduction
10.8.5 Lupin Pharmaceuticals Recent Development
10.9 Dr. Reddys Laboratories
10.9.1 Dr. Reddys Laboratories Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Levofloxacin
10.9.4 Levofloxacin Product Introduction
10.9.5 Dr. Reddys Laboratories Recent Development
10.10 Zydus Cadila
10.10.1 Zydus Cadila Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Levofloxacin
10.10.4 Levofloxacin Product Introduction
10.10.5 Zydus Cadila Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Levofloxacin Sales Channels
11.2.2 Levofloxacin Distributors
11.3 Levofloxacin Customers
12 Market Forecast
12.1 Global Levofloxacin Sales and Revenue Forecast 2019-2025
12.2 Global Levofloxacin Sales Forecast by Type
12.3 Global Levofloxacin Sales Forecast by Application
12.4 Levofloxacin Forecast by Regions
12.4.1 Global Levofloxacin Sales Forecast by Regions 2019-2025
12.4.2 Global Levofloxacin Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
